520
Participants
Start Date
March 31, 2005
Study Completion Date
February 28, 2007
tolevamer potassium-sodium (GT267-004)
New York
New Hyde Park
Albany
Syracuse
Pittsburgh
Pittsburgh
Lancaster
Allentown
Doylestown
Philadelphia
Philadelphia
Newark
Baltimore
Hagerstown
Winchester
Richmond
Richmond
Danville
Raleigh
Greenville
Asheville
Charleston
Greenville
Atlanta
Fort Gordon
Savannah
Jacksonville
Brandon
Zephyrhills
Tampa
Bay Pines
Brooksville
Hermitage
Ocean Springs
Louisville
Bowling Green
Toledo
Akron
Centerville
Anderson
Indianapolis
Muncie
Lafayette
Detroit
Detroit
Muskegon
Des Moines
Des Moines
Clive
Dubuque
Iowa City
Milwaukee
Marshfield
Eau Claire
Rochester
Rapid City
Fargo
Butte
Missoula
North Chicago
Hines
Maywood
Chicago
Decatur
St Louis
Kansas City
Everton
New Orleans
New Orleans
Rogers
Tyler
Houston
Denver
Denver
Denver
Phoenix
Phoenix
Los Angeles
Los Angeles
Los Angeles
Burbank
San Diego
Newport Beach
Modesto
Sacramento
Honolulu
Tacoma
Denver
Louisville
Boston
Boston
Worcester
Worcester
Lebanon
Cedar Knolls
Neptune City
Newark
Trenton
Burlington
Calgary
Edmonton
Kelowna
Kelowna
Vancouver
Victoria
Winnipeg
Winnipeg
Moncton
Saint John
Halifax
Ajax
Guelph
Hamilton
Kingston
London
Ottawa
Peterborough
Scarborough Village
Thunder Bay
Toronto
Toronto
Toronto
Toronto
Toronto
Windsor
Windsor
Chicoutimi
Green Field Park
Lévis
Montreal
Montreal
Montreal
Québec
Québec
Saint-Charles-Borromée
Saint-Hyacinthe
Sainte-Foy
Trois-Rivières
Saskatoon
San Juan
Genzyme, a Sanofi Company
INDUSTRY